ST-503
ST-503-101
Phase 2 gene_therapy active
Quick answer
ST-503 for Chronic Neuropathic Pain is a Phase 2 program (gene_therapy) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Chronic Neuropathic Pain
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active